PT-141 Research Overview
PT-141 is a synthetic cyclic heptapeptide originally developed as a melanocortin receptor agonist for laboratory investigation. This Dragon Pharma formulation provides researchers with 10mg of PT-141 (bremelanotide) in lyophilised powder form for in-vitro studies. The compound demonstrates selective binding affinity for melanocortin-4 receptors in preclinical models, making it valuable for researchers studying melanocortin signalling pathways and receptor pharmacology. As a derivative of the naturally occurring hormone α-melanocyte-stimulating hormone (α-MSH), PT-141 has undergone extensive laboratory evaluation for its receptor binding characteristics and downstream cellular responses.
Melanocortin Receptor Research Applications
Laboratory studies have focused on PT-141’s interaction with melanocortin receptors, particularly MC4R subtypes found throughout various tissue types. Research teams investigating this peptide have documented its effects on cyclic adenosine monophosphate (cAMP) signalling cascades in cell culture models. The compound’s unique cyclic structure, formed through lactam bridge formation between amino acid residues, contributes to its enhanced stability compared to linear peptide analogues. Researchers at Stroid UK Shop can access this high-purity formulation for studies examining melanocortin pathway modulation and receptor pharmacodynamics. Scientists studying PT-141 bremelanotide peptides have utilised this compound in comparative receptor binding assays alongside other melanocortin agonists. The peptide’s water-soluble properties facilitate reconstitution protocols for various experimental designs, from receptor binding studies to cellular signalling investigations. Additionally, researchers examining peptide stability and degradation kinetics have found PT-141 suitable for time-course experiments due to its enhanced resistance to enzymatic cleavage compared to native melanocortin hormones. Studies comparing SARMs and peptides often include PT-141 as a representative melanocortin receptor modulator in mechanistic investigations.
Technical Specifications
| Property | Specification |
|---|---|
| Chemical Name | PT-141 (Bremelanotide) |
| CAS Number | 189691-06-3 |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Molecular Weight | 1025.2 g/mol |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilised powder |
| Storage | -20°C, protect from light |
| Solubility | Water, bacteriostatic water |
Research Compliance Statement
PT-141 10mg Dragon Pharma is manufactured exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any form of in-vivo administration. Researchers must ensure compliance with all applicable laboratory safety protocols and institutional guidelines when handling this research peptide. All studies should be conducted within appropriate laboratory facilities with proper ventilation and safety equipment.
